TNDM logo

TNDM

Tandem Diabetes Care, Inc.NASDAQHealthcare
$18.61-1.06%ClosedMarket Cap: $1.27B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

8.16

P/S

1.25

EV/EBITDA

-10.00

DCF Value

$-46.45

FCF Yield

-2.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

53.8%

Operating Margin

-18.2%

Net Margin

-20.2%

ROE

-142.0%

ROA

-23.5%

ROIC

-27.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$290.4M$-589.0K$-0.01
FY 2025$1.01B$-204.7M$-3.04
Q3 2025$249.3M$-21.2M$-0.31
Q2 2025$240.7M$-52.4M$-0.78

Analyst Ratings

View All
Truist SecuritiesBuy
2026-03-19
Piper SandlerOverweight
2026-03-17
Morgan StanleyEqual Weight
2026-03-02
Lake StreetBuy
2026-02-23
Truist SecuritiesHold
2026-02-23

Trading Activity

Insider Trades

View All
Novara Mark Davidofficer: EVP & CHIEF COMMERCIAL OFFICER
SellWed Mar 18
Novara Mark Davidofficer: EVP & CHIEF COMMERCIAL OFFICER
SellWed Mar 18
Novara Mark Davidofficer: EVP & CHIEF COMMERCIAL OFFICER
SellWed Mar 18
Novara Mark Davidofficer: EVP & CHIEF COMMERCIAL OFFICER
SellMon Mar 09
Carpenter Rickofficer: Chief Technology Officer
SellThu Feb 19

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

1.74

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Peers